Identification of genes associated with chemotherapy crossresistance and treatment response in childhood acute lymphoblastic leukemia by Lugthart Sanne, Cheok Meyling H, den Boer Monique L, Yang Wenjian, Holleman Amy, Cheng Cheng, Pui Ching-Hon, Relling Mary V, Janka-Schaub Gritta E, Pieters Rob, Evans William E in Cancer cell (2005). PubMed

Abstract

Acute lymphoblastic leukemia (ALL) can be cured with combination chemotherapy in over 75% of children, but the cause of treatment failure in the remaining patients is unknown. We determined the sensitivity of ALL cells to individual antileukemic agents in 441 patients and used a genome-wide approach to identify 45 genes differentially expressed in ALL exhibiting crossresistance to prednisolone, vincristine, asparaginase, and daunorubicin. We also identified a distinct phenotype of discordant resistance to asparaginase and vincristine and 139 genes whose expression was associated with this novel phenotype. The expression of these genes discriminated treatment outcome in two independent patient populations, identifying a subset of patients with a markedly inferior outcome (37% +/- 13% 5 year DFS).

[ hide abstract ]

Discussed In Paper